about
Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection.Display technologies: application for the discovery of drug and gene delivery agents.Polyclonal rabbit anti-human ovarian cancer globulins inhibit tumor growth through apoptosis involving the caspase signaling.TMTP1, a novel tumor-homing peptide, specifically targets hematological malignancies and their metastases.Molecular mechanism of a novel CD59-binding peptide sp22 induced tumor cells apoptosis.Polyclonal rabbit anti-murine plasmacytoma cell globulins induce myeloma cells apoptosis and inhibit tumour growth in mice.Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.Development of recombinant human polyclonal antibodies for the treatment of complex human diseases.Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry.How to design multi-target drugs.Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells.Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.Construction of humanized carcinoembryonic antigen specific single chain variable fragment and mitomycin conjugate.Single-batch production of recombinant human polyclonal antibodies.Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies.Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis.Polyclonal Rabbit Anti-Cancer-Associated Fibroblasts Globulins Induce Cancer Cells Apoptosis and Inhibit Tumor Growth
P2860
Q33257951-AB82C181-697D-48DC-9D9E-A6E2711B8790Q33264491-F45B42F3-A9E6-4BA8-9AAA-287C1BD89E66Q33612686-DC8D31F8-2FC5-4B69-AE6D-3E05CF6806BAQ34061766-E8C90C6D-1A60-409B-8B02-D7230A4D06C7Q34347455-56A5389C-DE05-4300-8D07-9AF9A724A13DQ34733945-6D2A592B-A2BB-4518-9EC9-DE240F9E70C7Q36248755-A51815DC-8CB3-4AA6-BE65-5E3930AD59E7Q36569741-089476F9-C8B0-436F-8B17-02A1164D45ABQ37593690-11E9EA12-9A72-461A-BD9F-065DF0A0A554Q38089151-D89B9FA0-A431-4F2F-9E46-39BE94044038Q38685586-06B28F2E-6FC3-4041-AAE7-E889BF2702E4Q39270763-4A6D5539-556C-4E73-B366-D84F115663E3Q40061667-00C708ED-4D72-4BDC-A6B2-B0752FD77B82Q40898112-BD040FBA-388A-43F7-8B54-3FCE71F4995DQ41130070-1152C71B-8532-43EE-8B63-8977936E2D71Q51757125-FEBBE66A-7634-4855-8805-5D83B8A4122CQ58758002-D046A317-2AA3-47FA-B9DB-D2161BD6A7E7
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant polyclonal antibodies for cancer therapy.
@ast
Recombinant polyclonal antibodies for cancer therapy.
@en
type
label
Recombinant polyclonal antibodies for cancer therapy.
@ast
Recombinant polyclonal antibodies for cancer therapy.
@en
prefLabel
Recombinant polyclonal antibodies for cancer therapy.
@ast
Recombinant polyclonal antibodies for cancer therapy.
@en
P356
P1476
Recombinant polyclonal antibodies for cancer therapy.
@en
P2093
Brent R Williams
Meredith A Liebman
P2860
P304
P356
10.1002/JCB.20536
P577
2005-10-01T00:00:00Z